Titan Pharmaceuticals, Inc.
TTNP
$3.70
-$0.09-2.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.83M | 3.40M | 4.09M | 6.16M | 6.76M |
| Total Receivables | 62.00K | 52.00K | 38.00K | 134.00K | 1.05M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 30.00K | 151.00K | 220.00K | 318.00K | 199.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 13.00K |
| Total Current Assets | 2.92M | 3.60M | 4.35M | 6.61M | 8.02M |
|
|
|||||
| Total Current Assets | 2.92M | 3.60M | 4.35M | 6.61M | 8.02M |
| Net Property, Plant & Equipment | -- | -- | -- | 35.00K | 68.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.92M | 3.60M | 4.35M | 6.65M | 8.09M |
|
|
|||||
| Total Accounts Payable | 202.00K | 371.00K | 356.00K | 371.00K | 348.00K |
| Total Accrued Expenses | 281.00K | -- | -- | 155.00K | 519.00K |
| Short-term Debt | -- | -- | -- | -- | 500.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 33.00K | 65.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 12.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 12.00K |
| Total Current Liabilities | 483.00K | 371.00K | 356.00K | 559.00K | 1.44M |
|
|
|||||
| Total Current Liabilities | 483.00K | 371.00K | 356.00K | 559.00K | 1.44M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 500.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 483.00K | 371.00K | 356.00K | 559.00K | 1.44M |
|
|
|||||
| Common Stock & APIC | 398.98M | 398.98M | 398.98M | 398.98M | 398.47M |
| Retained Earnings | -396.54M | -395.75M | -394.98M | -392.89M | -391.83M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.44M | 3.23M | 3.99M | 6.09M | 6.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 1.00K | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | 2.44M | 3.23M | 3.99M | 6.09M | 6.64M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.44M | 3.23M | 3.99M | 6.09M | 6.64M |
|
|
|||||